Cardinal Health (CAH) Tops Q4 EPS by 7c; Guides Short of Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Cardinal Health (CAH) PT Lowered to $77 at Cowen Following 4Q Report
August 2, 2017 4:05 PM EDTCowen lowered its price target on Cardinal Health (NYSE: CAH) to $77.00 (from $82.00) while maintaining a Market Perform rating. CAH reported adjusted EPS of $1.31 that was above the consensus estimates of $1.24, but would have missed without a tax benefit.
Management announced F2018 adjusted EPS... More
